GARM II: A Study on the Genetics of Age-related Maculopathy

Active, not recruitingOBSERVATIONAL
Enrollment

603

Participants

Timeline

Start Date

October 6, 2011

Primary Completion Date

February 29, 2016

Study Completion Date

March 31, 2027

Conditions
Age-related Macular DegenerationAge-related Maculopathy
Interventions
OTHER

Observational-1

"Multiple questionnaires detailing family history, medical history, visual symptoms, smoking, environmental and dietary exposures.~Prospective photography of the retina to detect early ARM-related changes A saliva or blood sample for genetic testing."

OTHER

Observational-2

"A limited number of questionnaires and prior clinical documentation from eye care professionals of eye status with respect to ARM.~No prospective retina photographs but ongoing follow-up for reported changes in ARM status.~A saliva or blood sample for genetic testing."

Trial Locations (2)

15260

University of Pittsburgh, Pittsburgh

90095

Jules Stein Eye Institute, Dept. of Ophthalmology David Geffen School of Medicine at UCLA, Los Angeles

All Listed Sponsors
collaborator

Jules Stein Eye Institute

OTHER

collaborator

University of Pittsburgh

OTHER

collaborator

National Eye Institute (NEI)

NIH

lead

University of California, Los Angeles

OTHER

NCT01115387 - GARM II: A Study on the Genetics of Age-related Maculopathy | Biotech Hunter | Biotech Hunter